Annual Short Term Debt
$15.39 M
+$14.22 M+1225.21%
December 31, 2023
Summary
- As of February 7, 2025, ALDX annual short term debt is $15.39 million, with the most recent change of +$14.22 million (+1225.21%) on December 31, 2023.
- During the last 3 years, ALDX annual short term debt has risen by +$11.49 million (+295.20%).
- ALDX annual short term debt is now at all-time high.
Performance
ALDX Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$543.20 K
-$14.95 M-96.49%
September 30, 2024
Summary
- As of February 7, 2025, ALDX quarterly short term debt is $543.20 thousand, with the most recent change of -$14.95 million (-96.49%) on September 30, 2024.
- Over the past year, ALDX quarterly short term debt has dropped by -$12.98 million (-95.98%).
- ALDX quarterly short term debt is now -96.49% below its all-time high of $15.50 million, reached on June 30, 2024.
Performance
ALDX Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
ALDX Short Term Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +1225.2% | -96.0% |
3 y3 years | +295.2% | +144.5% |
5 y5 years | +100.0% | +148.0% |
ALDX Short Term Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +6601.1% | -96.5% | +136.6% |
5 y | 5-year | at high | +6698.8% | -96.5% | +358.8% |
alltime | all time | at high | -100.0% | -96.5% | -100.0% |
Aldeyra Therapeutics Short Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $543.20 K(-96.5%) |
Jun 2024 | - | $15.50 M(+0.3%) |
Mar 2024 | - | $15.45 M(+0.4%) |
Dec 2023 | $15.39 M(+1225.2%) | $15.39 M(+13.7%) |
Sep 2023 | - | $13.53 M(+124.5%) |
Jun 2023 | - | $6.02 M(+426.4%) |
Mar 2023 | - | $1.14 M(-1.4%) |
Dec 2022 | $1.16 M(+405.7%) | $1.16 M(-90.8%) |
Sep 2022 | - | $12.63 M(+144.4%) |
Jun 2022 | - | $5.17 M(+2090.0%) |
Mar 2022 | - | $236.00 K(+2.8%) |
Dec 2021 | $229.60 K(-94.1%) | $229.60 K(+3.3%) |
Sep 2021 | - | $222.20 K(+87.7%) |
Jun 2021 | - | $118.40 K(-97.8%) |
Mar 2021 | - | $5.27 M(+35.4%) |
Dec 2020 | $3.89 M(+1620.3%) | $3.89 M(+67.9%) |
Sep 2020 | - | $2.32 M(+129.5%) |
Jun 2020 | - | $1.01 M(+486.6%) |
Mar 2020 | - | $172.20 K(-23.9%) |
Dec 2019 | $226.30 K | $226.30 K(+3.3%) |
Sep 2019 | - | $219.00 K(+3.4%) |
Jun 2019 | - | $211.70 K(-4.3%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2019 | - | $221.10 K(>+9900.0%) |
Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
Sep 2018 | - | $465.30 K(+33.3%) |
Jun 2018 | - | $349.00 K(+50.0%) |
Mar 2018 | - | $232.60 K(+100.0%) |
Dec 2017 | $116.30 K(+50.1%) | $116.30 K(-72.7%) |
Sep 2017 | - | $426.50 K(+37.5%) |
Jun 2017 | - | $310.20 K(+60.0%) |
Mar 2017 | - | $193.90 K(+150.2%) |
Dec 2016 | $77.50 K(0.0%) | $77.50 K(-81.8%) |
Sep 2016 | - | $426.50 K(+37.5%) |
Jun 2016 | - | $310.20 K(+60.0%) |
Mar 2016 | - | $193.90 K(+150.2%) |
Dec 2015 | $77.50 K(0.0%) | $77.50 K(-75.0%) |
Jun 2015 | - | $310.20 K(+60.0%) |
Mar 2015 | - | $193.90 K(+150.2%) |
Dec 2014 | $77.50 K(-45.9%) | $77.50 K(-81.0%) |
Jun 2014 | - | $407.10 K(+5.0%) |
Mar 2014 | - | $387.70 K(+170.7%) |
Dec 2013 | $143.20 K(-14.1%) | $143.20 K(-14.1%) |
Dec 2012 | $166.70 K(-92.4%) | $166.70 K |
Dec 2011 | $2.20 M | - |
FAQ
- What is Aldeyra Therapeutics annual short term debt?
- What is the all time high annual short term debt for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics annual short term debt year-on-year change?
- What is Aldeyra Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics quarterly short term debt year-on-year change?
What is Aldeyra Therapeutics annual short term debt?
The current annual short term debt of ALDX is $15.39 M
What is the all time high annual short term debt for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high annual short term debt is $15.39 M
What is Aldeyra Therapeutics annual short term debt year-on-year change?
Over the past year, ALDX annual short term debt has changed by +$14.22 M (+1225.21%)
What is Aldeyra Therapeutics quarterly short term debt?
The current quarterly short term debt of ALDX is $543.20 K
What is the all time high quarterly short term debt for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high quarterly short term debt is $15.50 M
What is Aldeyra Therapeutics quarterly short term debt year-on-year change?
Over the past year, ALDX quarterly short term debt has changed by -$12.98 M (-95.98%)